Rosanna Sutherby, PharmD

Delgocitinib is first-in-class pan-Janus kinase inhibitor.

A recent study found that in Europe, approximately 1 in 5 individuals with chronic skin disease felt that they were looked at by others with disgust.

The melanocytes attacked by the autoimmune disease are present in the eyes and ears, not just the skin, so vitiligo can adversely affect vision and hearing.

Because vitiligo affects appearance, people with vitiligo are disproportionately affected by psychiatric conditions, including depression.

Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.